» Authors » Annika Kessler

Annika Kessler

Explore the profile of Annika Kessler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 11
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu K, Kessler A, Nichetti F, Hoffmeister-Wittmann P, Scherr A, Nader L, et al.
Liver Int . 2024 Aug; 44(11):2950-2963. PMID: 39164890
Background And Aims: Cholangiocarcinoma (CCA) is an aggressive malignancy arising from the intrahepatic (iCCA) or extrahepatic (eCCA) bile ducts with poor prognosis and limited treatment options. Prior evidence highlighted a...
2.
Scherr A, Nader L, Xu K, Elssner C, Ridder D, Nichetti F, et al.
Hepatology . 2023 Nov; 80(2):278-294. PMID: 37916976
Background And Aims: HCC is the most common primary liver tumor, with an increasing incidence worldwide. HCC is a heterogeneous malignancy and usually develops in a chronically injured liver. The...
3.
Hoffmeister-Wittmann P, Mock A, Nichetti F, Korell F, Heilig C, Scherr A, et al.
Liver Int . 2022 Aug; 42(12):2855-2870. PMID: 35983950
Intrahepatic, perihilar, and distal cholangiocarcinoma (iCCA, pCCA, dCCA) are highly malignant tumours with increasing mortality rates due to therapy resistances. Among the mechanisms mediating resistance, overexpression of anti-apoptotic Bcl-2 proteins...
4.
Sobol B, Nieto O, Eberlein E, Scherr A, Ismail L, Kessler A, et al.
Int J Mol Sci . 2022 Jul; 23(14). PMID: 35887198
Avoidance of therapy-induced apoptosis is a hallmark of acquired resistance towards radiotherapy. Thus, breaking resistance still challenges modern cancer therapy. The Bcl-2 protein family is known for its regulatory role...